TECH Statistiques clés
Haut
72.12
Ouverture
71.60
Volume
3.07M
Bas
71.50
Clôture précédente
71.77
Valeur négociée
221.03M
Plus haut 52 sem.
72.16
Vol. relatif
0.367
Amplitude (%)
0.86%
Plus bas 52 sem.
43.20
Taux de rotation
1.96%
Cap. Marché
11.18B
PER (TTM)
103.59
PER (Annuel)
153.447
P/B
5.39
P/S
9.28
Bénéfice par action (BPA)
0.696
Dividende (TTM)
0.317
Rendement du dividende
0.45%
Actions en circulation
156.56M
Devise
USD
TECH Performance du Prix
7 jour
30 jour
90 jour
180 jour
Depuis le début de l’année
1 An
TECH Répartition des flux monétaires
TECH Volume quotidien des ventes à découvert
TECH Historique du short interest
TECH Aperçu de l’action
As of 2026-07-18, the Bio-Techne Corp (TECH) stock price today is 72.12. Based on this price, the company has a market capitalization of $11.18B, with a P/E ratio of 103.59.
On 2026-07-18, TECH traded between 71.50 and 72.12. Today’s stock price is 0.87% above the daily low and 0.00% below the daily high, placing TECH proche de l’extrémité supérieure de its most recent trading range.
Trading volume currently stands at 3.07M, compared with an average daily volume of 8.38M. This suggests that trading activity is nettement inférieur à son niveau habituel than usual.
Over the past year, Bio-Techne Corp shares have traded between 43.20 and 72.16. At today’s price, TECH is 66.94% above its 52-week low and 0.06% below its 52-week high.
TECH Actualités liées
À propos TECH
Nom l'entreprise
Bio-Techne Corp
Secteur
Health Technology
Industrie
Biotechnology
Exchanges
Nasdaq
Nombre d’employés
3,100
Taille du lot
100
Site officiel
Devise
USD
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Related Stocks
© 2026 CoinGlass, all rights reserved
